haemagglutininum influenzae A (H1N1) (Virus souche A/Victoria/4897/2022 (H1N1)-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022) 60 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Darwin/9/2021 (H3N2)-like: reassortant virus SAN-010 derived from A/Darwin/9/2021) 60 µg, haemagglutininum influenzae B (Virus souche B/Austria/1359417/2021-like: derived from B/Michigan/01/2021 (Victoria lineage)(wild type)) 60 µg, haemagglutininum influenzae B (Virus souche B/Phuket/3073/2013 (Yamagata lineage) (wild type)) 60 µg, natrii chloridum, dinatrii phosphas, natrii dihydrogenophosphas anhydricus, octoxinolum-9, aqua ad iniectabile q.s. ad suspensionem pro 0.7 ml corresp. natrium 2.72 mg.
Packungsbestandteile
suspension injectable en seringue préremplie
Active Agent
Dose
Haemagglutininum Influenzae a (H1N1) (Virus Souche A/victoria/4897/2022 (H1N1)-Like: Reassortant Virus Ivr-238 Derived from A/victoria/4897/2022)
60µg / 0.7ml
Haemagglutininum Influenzae a (H3N2) (Virus Souche A/darwin/9/2021 (H3N2)-Like: Reassortant Virus San-010 Derived from A/darwin/9/2021)
60µg / 0.7ml
Haemagglutininum Influenzae b (Virus Souche B/austria/1359417/2021-Like: Derived from B/michigan/01/2021 (Victoria Lineage)(wild Type))
60µg / 0.7ml
BAG: Active Agent
Dose
Influenza-haemagglutinin
240 mcg
Inactive agents
Dose
Disodium Phosphate
Haemagglutininum Influenzae b (Virus Souche B/phuket/3073/2013 (Yamagata Lineage) (Wild Type))
60µg / 0.7ml
Sodium Chloride
Sodium Dihydrogenophosphate Anhydrate
Octoxinolum-9
Source
Data was imported : 05.09.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
